INTRODUCTION
Myocarditis has been historically defined as an acute disease process
which results in myocardial inflammation and necrosis(1). The often-resultant
impairment in myocardial function increases the predisposition to the
development of a non-ischemic cardiomyopathy, which has been shown to
result in poor prognostic outcomes such as chronic congestive failure,
cardiac arrhythmias and sudden cardiac death(1). Whilst the gold-standard
investigation is cardiac magnetic resonance (CMR), the initial
non-invasive assessment typically utilised is transthoracic
echocardiography (TTE), as it is widely available, easily accessible,
and cost-effective within most healthcare settings